The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

compared to about 16% of those taking Wegovy, the AP reported, citing the study. Researchers explained in the study that ...

Fact checked by Jennifer Klump People who use Wegovy for weight management may be at higher risk for hair loss, according to ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

(Note: The Hers platform offers access to Wegovy, if prescribed, for people 18 and older, at 50 percent off the retail price.) It’s a powerful tool for weight loss, but it’s not a magic ...

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Another interesting finding was that women in both ... clearly led to more weight loss in this trial. But it’s worth mentioning that when Wegovy was tested at a much higher dose of 7.2 ...

compared to about 16% of those taking Wegovy, the study found. Weight loss was about 6% lower in men than in women in both groups, the authors noted. As participants in both groups lost more ...

Connecticut homebuyers seek savings in a high ... their body weight, compared to about 16% of those taking Wegovy, the study found. Weight loss was about 6% lower in men than in women in both ...